Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma

NCT00079755

Conditions
Anaplastic Large-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • University of Califorinia at Los Angeles Los Angeles, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of Miami Miami, Florida, United States
View all 18 locations
View Trial Details
Completed

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

NCT01026233

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Miami Hospital and Clinics, Miller School of Medicine Miami, Florida, United States
View Trial Details
Completed

Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation

NCT01767714

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Investigational Site Number 156017 Beijing, China
  • Investigational Site Number 156001 Beijing, China
  • Investigational Site Number 156005 Beijing, China
  • Investigational Site Number 156002 Beijing, China
View all 16 locations
View Trial Details
Completed

A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT

NCT00460421

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Loma Linda University Loma Linda, California, United States
  • Children´s Hospital Los Angeles, California, United States
  • Regents of University of California Los Angeles, California, United States
View Trial Details
Completed

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

NCT00666484

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • University College Hospital - London London, England, United Kingdom
  • King's College Hospital London, England, United Kingdom
  • Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle upon Tyne, England, United Kingdom
View Trial Details
Completed

Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

NCT00971763

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Sussex Cancer Centre at Royal Sussex County Hospital Brighton, England, United Kingdom
  • Leeds General Infirmary Leeds, England, United Kingdom
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • Cancer Research UK and University College London Cancer Trials Centre London, England, United Kingdom
View Trial Details

Related conditions